FDA Inspection 1115250 — Qilu SYNVA Pharmaceutical Co. Ltd
The FDA completed an inspection of Qilu SYNVA Pharmaceutical Co. Ltd on December 13, 2019 in Dezhou. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Veterinary.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 13, 2019
- Fiscal Year
- 2020
- Product Type
- Veterinary
- Project Area
- Pre-Approval Eval. of Animal Drugs and Food Additives
- Location
- Dezhou (China)